Diagnostica Stago

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Diagnostica Stago sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials none currently recruiting 3 completed upper quartile by trial count

Diagnostica Stago: 5 sponsored US clinical trials, none currently recruiting.

Diagnostica Stago sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Anticoagulation With Apixaban, with 1 trials.

Upper-quartile sponsor footprint

Diagnostica Stago sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

How the Diagnostica Stago archive is shaped

5 indexed studies, none listed as recruiting (0% open); 3 completed (60%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Anticoagulation With Apixaban (1 trial), 1 other listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Diagnostica Stago: archived-pipeline peers nationwide

Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Diagnostica Stago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20%25% Total trials Recruiting share Diagnostica Stago4YouandMeAbbott Rapid DxAccess Business GroupAcera Surgical10xBio22nd Century Group23andMe3-C Institute for Social Development
Diagnostica Stago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Diagnostica Stago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 archived trials

Sponsors with similar archive density (± trial count)

What to do with this Diagnostica Stago page

5 registered trials is a research-attention snapshot, not an endorsement of Diagnostica Stago or any single study.

  • None of Diagnostica Stago's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Anticoagulation With Apixaban is the condition Diagnostica Stago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anticoagulation With Apixaban trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Diagnostica Stago pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.